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Summary
Background—Rising body weight is a major public health concern. However there have been 
few worldwide comparative analyses of long-term trends of body mass index (BMI), and none that 
have used recent national health examination surveys.
Methods—We estimated trends in mean in BMI and their uncertainties for adults 20 years of age 
and older in 199 countries and territories. Data were from published and unpublished health 
examination surveys and epidemiologic studies. For each sex, we used a Bayesian hierarchical 
model to estimate BMI by age, country, and year, accounting for whether a given study was 
nationally representative.
Findings—Between 1980 and 2008, global mean BMI increased at an annualized rate of 0.4 
(95% uncertainty interval 0.2, 0.6, posterior probability (PP) of being a true increase > 0.999) 
kg/m2/decade for men and 0.5 (0.3–0.7, PP > 0.999) for women. National BMI change for women 
ranged from non-significant declines in 19 countries to rising over 2.5 (PP > 0.999) kg/m2/decade 
in Tonga and Cook Islands. There was an increase in male BMI in all but a few countries, 
reaching over 2 kg/m2/decade in Nauru and Cook Islands, PP > 0.999. Male and female BMIs in 
2008 were highest in some Oceania countries, reaching 33.9 (32.8, 35.0) kg/m2 (men) and 35.0 
(33.6, 36.3) (women) in Nauru. Female BMI was lowest in Bangladesh (20.5; 19.8, 21.3) kg/m2 
and male BMI in Democratic Republic of the Congo 19.9 (18.2, 21.5), with BMI also below 21.5 
kg/m2 for both sexes in a few countries in sub-Saharan Africa, and East, South, and Southeast 
Asia. USA had the highest BMI among high-income countries, followed by New Zealand. In 
2008, an estimated 1.47 billion adults worldwide had BMI ≥ 25 kg/m2; of these 205 (193, 217) 
million men and 297 (280, 315) million women were obese.
Interpretation—Globally, mean BMI increased since 1980. The trends since 1980, and mean 
population BMI in 2008, varied substantially across nations. Interventions and policies that can 
curb or reverse the increase, and mitigate the health effects of high BMI by targeting its metabolic 
mediators, are needed in most countries.
Introduction
Excess body weight is an important risk factor for mortality and morbidity from 
cardiovascular diseases, diabetes, cancers, and musculoskeletal disorders, causing nearly 3 
million annual deaths worldwide1–4. National, subnational, and multi-center studies have 
shown that adiposity, as measured by body mass index (BMI, calculated as weight in kg 
Finucane et al. Page 2
Lancet. Author manuscript; available in PMC 2015 June 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
over m2), has increased in recent decades in many populations5–12, although BMI seems to 
have been stable or even decreased in some groups6–7, 9, 13.
Some have argued that rising BMI is a pandemic14–15 that may reverse life expectancy gains 
in high-income nations16. Therefore, there is enormous interest in curbing or reversing rising 
BMI trends. Reliable information on BMI trends in is needed to assess its population health 
effects, set policy priorities, and evaluate their success. A number of studies used national 
health surveys, multi-center studies, and/or reviews of published studies to estimate adult 
BMI levels or trends worldwide, specific regions, or cross-country comparative 
analyses6, 17–21. Some of these studies used BMI data based on both measured and self-
reported weight and height19, even though the latter is biased22. Others focused exclusively 
on women20 or selected countries6, 19–21, relied primarily on community studies6, 17, or 
combined community and national studies without distinguishing them18. Recently, many 
high-quality national health examination surveys have measured BMI, providing an 
opportunity to systematically and comprehensively assess regional and national trends.
We reviewed and accessed published and unpublished studies to collate comprehensive BMI 
data. We developed and applied statistical methods to systematically address measurement 
comparability, missing data, non-linear trends and age patterns, and national vs. subnational 
and community representativeness. Using these data and methods, we estimated BMI trends 
and their uncertainties by country between 1980 and 2008.
Methods
Overview
We estimated 1980–2008 trends in mean BMI and their uncertainties, by sex, for 199 
countries and territories in 21 subregions of the Global Burden of Diseases, Injuries, and 
Risk Factors Study, themselves grouped into seven regions (Webtable 1)23. 1980 was 
selected as the beginning of the analysis period because fewer data were available earlier.
There is evidence that central adiposity measures, e.g. waist circumference, may better 
predict disease risk at the individual level24–25; other evidence indicates that central 
adiposity and BMI independently predict mortality risk26. However, many more population-
based studies have measured BMI than central adiposity. We used mean BMI, instead of 
obesity prevalence, as our main outcome because the association with most diseases is 
continuous2–3. We also report overweight and obesity because, while not as relevant for 
population health as mean BMI, they are commonly used for public communication.
Our analysis included three steps:
1. Identifying data sources, and accessing and extracting data;
2. Converting extracted data to a comparable metric; and
3. Applying a statistical model to estimate BMI trends by country and sex.
We analyzed the uncertainty in estimates, taking into account sampling error and uncertainty 
from statistical modeling in steps 2 and 3.
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Data identification, access and extraction
We obtained data from health examination surveys and epidemiologic studies with 
anonymized data available to Collaborating Group members; multi-center studies; a review 
of published articles; and unpublished data identified through the WHO global Infobase 
(Figure 1 and Webappendix 1). Duplicate sources of data were identified by comparing all 
studies from the same population-year (e.g., when data from a MONICA Project site was 
also reported separately); the source with more detail was used. Importantly, only BMI data 
from measured weight and height were used because self-reported measures are 
systematically biased22.
Health examination surveys and other epidemiologic studies with available 
individual records—Collaborating Group members analyzed anonymized data from 
health examination surveys and epidemiologic studies. BMI mean was calculated by sex and 
age group, incorporating appropriate sample weights when applicable.
Review of published articles—We identified data sources by searching Medline and 
Embase for relevant articles, with detailed information on the search strategy, exclusion 
criteria, and the number of articles identified and retained provided in Webappendix 1 and 
Figure 1. In brief, studies were included if they were from a population-based sample, 
including from a national, subnational, and community population, and if the data were 
based on measured (vs. self-reported) BMI (see Webappendix 1 for exclusion criteria 
details). If a published article met the inclusion criteria but did not report data by age and 
sex, we invited the corresponding author to join the Collaborating Group by contributing 
stratified data. There were no restrictions on the language of publication. All articles for 
which we could identify a translator were screened for inclusion in the data sources.
Additional published and unpublished data sources—We identified additional 
data sources through personal communications with researchers, including inquiring about 
additional data from authors of published studies. This led to access to data from multi-
center studies (e.g. the MONICA Project and INTERSALT and INTERMAP Studies), 
published government reports, published sources not identified in our review, as well as 
unpublished data. These data were used only if information on study population and 
measurement methods were available. We applied the same exclusion criteria to these data 
sources as to the published articles.
Data extraction—Age-and-sex-stratified data were extracted into standard data extraction 
files. Extracted data included information on mean BMI and/or prevalence of overweight/
obesity; sample sizes, standard errors and/or confidence intervals; survey population and 
sampling strategy; and selected other study characteristics (Webtable 2). When sample 
weights were provided, we calculated weighted mean BMI. Importantly, for each data 
source we recorded (i) whether the data were national (separated into weighted and 
unweighted), covered multiple subnational regions, or were from individual communities 
(denoted “coverage” hereafter) and (ii) whether the study population was rural, urban, or 
both (Webtable 2). This information was used to account for potential bias and additional 
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uncertainty in data sources that were not representative of their national populations, as 
described below.
Methods for comparability of BMI metrics and for estimating the prevalences of 
overweight and obesity
Some published studies reported overweight/obesity prevalence, but not mean BMI, which 
was our primary outcome. In such cases, we developed linear regressions to estimate mean 
BMI from overweight/obesity prevalence (Webappendix 3; Webtable 3). The dependent 
variable in these “cross-walking” regressions was mean BMI; the independent variables 
were overweight/obesity prevalence, age, sex, year of survey, and whether the country was 
high-income. A separate regression was developed for each overweight/obesity prevalence 
definition used in at least one published study. The details of the cross-walking regression 
models and their coefficients are provided in Webappendix 3 and Webtable 3.
A similar approach was also used to estimate overweight (BMI ≥ 25 kg/m2) and obesity 
(BMI ≥ 30 kg/m2) prevalences, which were our secondary outcomes, using estimates of 
mean BMI from our model. For this analysis, we applied regression models to mean BMI by 
age group, sex, country and year, to estimate either the prevalence of overweight or that of 
obesity. The dependent variable in each of these two regressions was the logit of prevalence 
and the independent variables were mean BMI and the same covariates as above. We used 
logit transformation to restrict the estimated prevalences between 0 and 1. The uncertainty 
of the estimated prevalences included those of the estimated country mean (see below) and 
uncertainty associated with converting mean to prevalence. Subregion estimates for each 
year were simply calculated as population-weighted averages of the country estimates by 
age group and sex. The details of these “reverse cross-walking” regressions and their 
coefficients are provided in Webappendix 3 and Webtable 4.
Statistical methods for country estimates
Despite our extensive data access, there were many country-years without data or without 
nationally representative data, because annual risk factor data are available for very few 
countries. Further, some studies covered only some age-sex groups or only rural or urban 
populations. We developed a statistical model for estimating mean BMI over time, by age 
group, sex, and country. We conducted all analyses by sex, because males and females can 
differ in BMI levels and trends9. We used a Bayesian hierarchical model to make estimates 
for each age-country-year unit; the estimates were informed by data from that unit itself, if 
available, and also by data from other units. Specific model features, and their motivations, 
are briefly described below; complete details are provided in Webappendix 2.
• We used a hierarchical model in which BMI levels and trends in countries were, in 
turn, nested in subregional, regional and global levels and trends. The hierarchical 
model “borrows information” across countries, subregions, and regions, 
appropriately compromising between (overly) uncertain within-unit estimates and 
the (overly) simplified aggregate cross-unit estimates; it borrows information to a 
greater degree when data are nonexistent or noninformative (i.e. have large 
uncertainty), and a lesser degree in data-rich countries, subregions, and regions.
Finucane et al. Page 5
Lancet. Author manuscript; available in PMC 2015 June 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
• Trends over time were modeled as nonlinear, consisting of a linear trend plus a 
smooth nonlinear trend at all levels. Both components were modeled hierarchically.
• Time-varying country-level covariates informed the estimates. The covariates, 
described elsewhere27, were (i) national income (Ln per-capita GDP converted to 
international dollars in 1990), (ii) urbanization (proportion of population that lived 
in urban areas), and (iii) national availability of multiple food types. The 
associations of BMI with the first two covariates were allowed to change over time, 
e.g. because income association may change as social and scientific factors 
influence diet and physical activity. To reduce the influence of inter-annual 
fluctuations of covariates and to reflect potentially cumulative associations, we 
used a weighted average of the past ten years, with progressively smaller weights in 
the more distant past.
• Subnational and community studies may systematically differ from nationally-
representative ones, because they may be conducted in low- or high-BMI areas. 
They may also have larger variation than national studies. Our model included 
time-varying offsets for subnational and community data, and additional variance 
components for subnational and community data and for national data without 
sample weights. These variance components (estimated empirically) allowed 
national data with sample weights to have more influence on estimates than other 
sources.
• BMI may differ systematically between rural and urban populations, with the 
difference depending on the country’s urbanization level. Therefore, the model 
accounted for differences between study- and country-level urbanization.
• Mean BMI may be non-linearly associated with age and may decline in older ages. 
The age association of BMI may vary across countries, and may be steeper where 
mean BMI is higher. Therefore, we used a cubic spline age model, with parameters 
estimated as a function of BMI at a baseline age.
Mean BMI was estimated from the model by 5–10 age groups for adults ≥ 20 years. 
Subregional and regional estimates for each year were calculated as population-weighted 
averages of the country estimates by age group and sex. For presentation, age-specific 
estimates for each country/region and year were age-standardized using WHO’s reference 
population28, which corresponds to the 2000–2025 world population.
Analysis of uncertainty
We quantified the following sources of uncertainty, with details provided in Webappendix 2.
• sampling uncertainty in the original data sources;
• uncertainty associated with inter-annual fluctuations in weighted national data, due 
to unmeasured study design factors (e.g. see national data from USA and Egypt in 
Webfigure 5);
• additional uncertainty associated with data sources that were not weighted national, 
due to variation across subgroups within each country;
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• uncertainty associated with statistical methods for comparability of BMI metric; 
and
• uncertainty due to using a model to estimate mean BMI by age group, country, and 
year when data were missing.
As described in Webappendix 2, we fit the Bayesian model using Markov chain Monte 
Carlo (MCMC) and obtained samples from the posterior distribution of model parameters, 
reflecting the above sources of uncertainty, which were in turn used to obtain the posterior 
distribution of mean BMI. The uncertainty intervals reported in Results represent the 2.5th–
97.5th percentiles of the posterior distribution of estimated means from the Bayesian model. 
We also report the posterior probability (PP) that an estimated increase/decrease corresponds 
to a truly increasing/decreasing BMI trend. Change was estimated as linear trend over the 28 
years of analysis and is reported as change per decade. Note that PP is not a p-value; PP 
would be 0.50 in a country or region where an increase is indistinguishable from a decrease, 
and larger PP indicates more certainty.
Role of funding sources
The sponsor of the study had no role in study design, data collection, data analysis, data 
interpretation, writing of the report, or decision to submit manuscript. The Writing and 
Global Analysis Group had access to all data sources and has responsibility for the contents 
of the manuscript and the decision to submit.
Results
Our analysis included 960 country-years of data, with a total of 9.1 million participants 
(Figure 1). Of these, 361 country-years were from 29 high-income countries and 599 
covered 140 additional countries. Japan had the most national data with 16 national data 
sources since 1980, followed by China with 8 national sources and 64 subnational or 
community sources. There were about 30 countries for which we could not identify any 
data. The Caribbean had the most countries with no usable data (7 of 20).
There were more data for women (931 country-years) than men (796), especially in sub-
Saharan Africa and other low-and-middle-income regions, where 28% of sources, primarily 
Demographic and Health Surveys, had only female data (Webfigure 1 and Webfigure 2). 
More than one half of sources did not have data over 70 years of age. About one half of data 
in low-and-middle-income regions were from the 2000s (59% of national data), and another 
34% from the 1990s, whereas in high-income regions data were evenly distributed over 
time.
Between 1980 and 2008, age-standardized mean BMI for men increased in every subregion 
except Central Africa and South Asia. The global change was 0.4 (95% uncertainty interval 
0.2, 0.6, PP of being a true increase > 0.999) kg/m2/decade, ranging from −0.2 (−1.3, 0.9, 
PP=0.61) kg/m2 in Central Africa to 1.3 (0.6, 2.0, PP > 0.999) kg/m2 in Oceania. Male BMI 
in six other subregions increased by 0.9–1.1 kg/m2/decade (Figure 2). In fact there was an 
increase in male BMI in all but eight countries, with 173 countries having PP of being a true 
increase ≥ 0.75 (Figure 3). Among high-income countries, male BMI rose most in USA (1.1, 
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0.9, 1.3 kg/m2/decade, PP > 0.999), followed by UK and Australia, and least in Brunei 
Darussalam, Switzerland, Italy and France, with increases ranging 0.3–0.4 kg/m2/decade.
In 2008, age-standardized mean BMI among men was highest in Australasia and North 
America, 27.6 (27.1, 28.1) and 28.4 (279, 28.7) kg/m2, respectively. Male BMI was lowest 
in sub-Saharan Africa and in East, South, and Southeast Asia, ranging 20.6–22.9 kg/m2. As 
a result of the differential trends, the gap between subregions with the highest and lowest 
male BMI increased from 5.4 in 1980 to 7.8 kg/m2 in 2008. The highest male BMI in 2008 
was in some countries in Oceania (Figure 4 and Webfigure 5), reaching 33.9 (32.8, 35.0) in 
Nauru. Men in some countries in the Caribbean and North Africa and Middle East and in 
USA also had mean BMI above 28 kg/m2. The lowest estimated male BMIs, all below 21 
kg/m2, were seen in a few countries in sub-Saharan Africa and South and Southeast Asia. 
Japan and Singapore had the lowest male BMI among high-income countries, both below 
24.0 kg/m2.
Globally female BMI increased by 0.5 (0.3, 0.7, PP > 0.999) kg/m2/decade between 1980 
and 2008. The largest rise in female BMI also occurred in Oceania (1.8; 1.0, 2.7 kg/m2/
decade, PP > 0.999), followed by BMI rises of 1.3–1.4 kg/m2/decade in Southern and 
Central Latin America. Female mean BMI trends in Central and Eastern Europe and Central 
Asia were indistinguishable from being flat, with changes < 0.2 kg/m2/decade and PP of 
change < 0.65. The increase in East and South Asia, Asia-Pacific, and Western Europe was 
also below 0.4 kg/m2/decade. The latter two high-income regions were noticeably different 
from Australasia and North America where female BMI increased by about 1.2 kg/m2/
decade, pp > 0.999.
Nationally, female BMI decreased in 19 countries with posterior probabilities ranging 0.50–
0.81. Of the remaining 180 countries, BMI rose in 76 with PP > 0.975. The largest of these, 
with an average rise of ≥ 2.0 kg/m2/decade occurred in 9 countries in Oceania (Figure 3). 
Women in Australia, New Zealand and especially USA (1.2, 0.9, 1.5, PP > 0.999) led high-
income countries in weight gain, with those in Italy and Singapore possibly having a modest 
BMI decline of 0.1–0.2 kg/m2/decade(PP < 0.75).
Globally age-standardized mean BMI in 2008 was 23.8 (23.6, 24.0) kg/m2 for men and 24.1 
(23.9, 24.4) kg/m2 for women. Men had higher BMI than women in high-income 
subregions, and lower BMI in most low- and middle-income regions. While the difference 
between the lowest and highest mean female BMI across subregions was about 7 kg/m2 in 
both 1980 and 2008, ordering changed. In 1980, women in Central and Eastern Europe and 
Southern Africa, with mean BMI of 25.8–26.6 kg/m2, had the highest BMI; in 2008, the top 
female BMIs were in North America, North Africa and Middle East, and Southern Africa, 
all ≥ 28 kg/m2. At the other extreme, in 1980 the lowest female BMI was in low-income 
subregions of Central, East, and West Africa and South and Southeast Asia, all ≤ 21.2 
kg/m2; in 2008, West Africa and Southeast Asia were replaced by East Asia and high-
income Asia-Pacific subregions, with BMIs ranging 21.4–22.9 kg/m2. As with males, 
women in countries in Oceania had the highest BMI, with mean BMI in Nauru (35.0; 33.6, 
36.3 kg/m2) being the highest of any country. Female BMI was also ≥ 29 kg/m2 in a number 
of countries in North Africa and Middle East and Caribbean, and in South Africa.
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American women had the highest mean BMI among high-income countries, and at 28.3 
(27.7, 28.9) kg/m2 were almost one full unit of BMI more overweight than the next highest, 
New Zealand. Women in a number of countries in East, South, and Southeast Asia and East 
Africa had mean BMI below 21.5 kg/m2, > 14 kg/m2 lower than those in Tonga and Nauru. 
Japanese women, with mean BMI of 21.9 (21.3, 22.4) kg/m2 were more similar to these 
low-BMI countries than most Western high-income ones.
Men in the world’s two most populous countries had mean BMIs that were 1–2 kg/m2 lower 
than the world average in 2008 (Figure 4). Male BMI in China, increased faster than the 
global mean, but in India the trend was estimated to be flat. Women in China and India had 
mean BMIs 1–2.5 kg/m2 lower than the global average; female BMI increase was less than 
the global mean in both countries. Despite the increases in BMI, both countries were among 
the 30% of countries with the lowest male and female mean BMI in 2008.
Worldwide, age-standardized prevalence of obesity was 9.8% (9.2, 10.4) among men and 
13.8% (13.1, 14.7) among women in 2008, higher than about twice the 1980 prevalences of 
4.8% (4.0,5.7) (men) and 7.9% (6.8, 9.3) (women) (Figure 4). An estimated 205 (193, 217) 
million men and 297 (280, 315) million women above the age of 20 years worldwide were 
obese in 2008; 1.47 billion adult men and women had BMI ≥ 25 kg/m2. The prevalence of 
obesity in 2008 was highest in North America among men, with an age-standardized 
prevalence of 29.2% (26.7, 31.8), and in Southern Africa among women 36.4% (32.8, 39.9). 
Female obesity prevalence was also > 30% in North America and three other low-and-
middle-income subregions. Obesity prevalence was lowest in South Asia among both men 
(1.4%; 1.0, 2.1) and women (2.9%; 2.0, 4.0), followed by Central and East Africa for men 
and high-income Asia-Pacific and Central and East Africa for women.
Discussion
Between 1980 and 2008, age-standardized mean global BMI increased by 0.4–0.5 kg/m2/
decade among men and women. As relevant as the average rise were the similarities and 
differences across regions and sexes. Notably, the subregion trends spanned a 1.4 and 1.9 
kg/m2/decade range for men and women, respectively, with BMI rise largest in Oceania in 
both sexes. The regions with virtually flat trends or even potential declines for women were 
Central and Eastern Europe whereas for men they were Central Africa and South Asia. An 
implication of these heterogeneous trends was an increasing gap between the lowest and 
highest BMI subregions for men and a reordering for women.
Our results on both BMI rise, and its rare stability, are consistent with national and multi-
center studies5–13, 19–20. For example, we estimated small trends among women in Brazil, 
Japan, and Taiwan; previous studies found increases in some groups and stable or 
decreasing trends in others7, 9, 29. Our estimated stable or decreasing trends in Central and 
Eastern Europe (for women) were also consistent with other analyses6, 30.
The strengths and innovations of this study include analysis of long-term trends; amount of 
high-quality measured population-based data accessed and used, including data on either 
mean BMI or overweight/obesity prevalence, and systematically converting all metrics to 
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mean BMI; the Bayesian hierarchical model for estimating mean BMI, incorporating non-
linear age associations and time trends; incorporating study coverage as offset and variance 
components in the statistical model; and systematic analysis of uncertainty. Coverage-
specific offsets and variances allowed our estimates to use all available data and to follow 
data from nationally-representative studies more closely than other sources. Further, the 
coverage-specific variance components are larger for less representative data sources; this 
results in larger uncertainty where we did not have nationally-representative data, 
propagating through the Bayesian model into our uncertainty intervals, thereby representing 
the true availability of information. The main limitation of our study is that data gaps 
remained despite our extensive data seeking, especially in the 1980s, and for men through 
1990s. Our analysis did not consider trends in central adiposity due to a lack of population-
based data, nor did it quantify within-country disparities by socioeconomic status or 
race31–33. Underweight, specifically as measured by low BMI, was not an outcome of our 
study. While most research on undernutrition has focused on child growth and increased risk 
of mortality from infectious diseases, maternal low BMI is a risk factor for neonatal 
mortality34. We found that in 1980, mean female BMI in several countries in sub-Saharan 
Africa and South and Southeast Asia was below 19 kg/m2, which indicates that significant 
proportion of the population would be clinically underweight (BMI ≤ 18.5). By 2008, lowest 
mean female BMIs had reached around 21 kg/m2, indicating that underweight has decreased 
but may still affect some populations. Finally, we did not estimate childhood and adolescent 
adiposity which is important because childhood weight gain may have larger adverse effects 
than weight gain during adulthood due to the longer exposure.
While our estimates have quantitative uncertainty, the relatively large amount of data used 
makes our conclusions relatively robust. There may however be less consensus about the 
interpretation of the findings and their research and policy implications. Undoubtedly, 
research is needed on the proximal and distal causes of the observed trends. For example, to 
what extent have changes in physical activity vs. increases in caloric intake or changes in 
dietary composition been responsible for BMI rise35–36? What explains the heterogeneous 
BMI levels and trends, including by sex, among high-income countries (Asia-Pacific vs. 
Western Europe vs. Australasia and North America) or among Africa’s subregions?
Learning from our understanding of the causes of observed trends, and as we investigate and 
debate these causes37, we should design and rigorously test interventions and policies that 
curb or reverse the harmful trends, or attenuate their adverse effects through reducing 
mediators such as blood pressure and lipids38. Randomized studies of diet change, some also 
increasing exercise, have found moderate weight loss benefits for periods up to two 
years39–41 but long-term and community effectiveness of such interventions is less clear42. 
Simple advice and exercise-alone have not been efficacious even in trials41. Structural, 
regulatory, and economic interventions have potential to change physical activity or dietary 
patterns at the population level43–44, but few have demonstrated effects on weight45. 
Support for interventions on metabolic mediators comes from effectiveness and cost-
effectiveness based on randomized trials46–48 and more importantly from the fact that many 
countries have successfully reduced blood pressure and lipids despite rising BMI6, 27, 49, by 
a larger amount among those at higher BMI50. While such interventions may reduce the 
effects of BMI on cardiovascular diseases, they do not address effects on other chronic 
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diseases, especially diabetes for which investigation of pharmacological interventions 
effects on cause-specific and total mortality is ongoing51–54.
Finally, we should carefully analyze the mortality and morbidity effects of high BMI, and of 
interventions. Recent international cohort and case-control studies have quantified the 
associations between high BMI and different diseases in populations worldwide2–3, 25. 
Additional research is needed on how the duration of being overweight or obese influences 
risk, and whether the health benefits of preventing weight gain and those of weight loss are 
similar55–56.
Our systematic analysis of population-based data sources helped unpack the “global obesity 
pandemic” into its constituent trends by country, region and sex. As we design and 
implement interventions and policies to address this important risk factor, high-quality 
national surveillance is essential to provide reliable data for setting priorities and evaluating 
such efforts.
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Figure 1. 
Flow diagram for data identification and access.
Finucane et al. Page 15
Lancet. Author manuscript; available in PMC 2015 June 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Finucane et al. Page 16
Lancet. Author manuscript; available in PMC 2015 June 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
Trends in age-standardized mean BMI by subregion between 1980 and 2008. See Webfigure 
4 for trends by region and Webfigure 6 for trends by country. The solid line represents the 
posterior mean estimate and the shaded area the 95% uncertainty interval.
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Figure 3. 
Change in country age-standardized BMI between 1980 and 2008 in relation to its 
uncertainty.
The shaded areas approximately represent the following ranges of posterior probabilities 
(PP) of an estimated increase/decrease being a true increase/decrease:
A: PP > 0.975
B: 0.95 < PP < 0.975
C: 0.75 < PP < 0.95
D: PP < 0.75
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Figure 4. 
Age-standardized BMI in (a) 1980 and (b) 2008 by country.
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Figure 5. 
Prevalences of (a) obesity (BMI ≥ 30 kg/m2) and (b) overweight (BMI ≥ 25 kg/m2) in 1980 
and 2008.
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